GHO Capital, a specialist healthcare investment firm, agreed to invest in Biocare Medical, a provider of oncology-focused diagnostic reagents and instrumentation. Excellere Partners, a US-based private equity firm, shall remain a significant partner in the company. Financial terms were not disclosed. “We are very pleased to be working closely with GHO and Excellere to accelerate our focus and investment in R&D in order to deliver on our ambitious portfolio expansion targets. With GHO, we have found a strong specialist partner to complement our existing capital partner, both of whom truly understand our business, and are excited to support the next chapter of Biocare’s strategic vision and growth," Luis de Luzuriaga, Biocare CEO.